CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. This guide aims to demystify the process, offering practical advice and insights to help patients make informed decisions.

Dispensary 52

Dispensary Patients Marijuana Education 52

Veriheal

JUNE 21, 2023

There will also be measures put in place to control therapeutic access to psilocybin while awaiting federal reform. If approved by the Food and Drug Administration (FDA), this psychedelic would be used to treat chronic and life-threatening mental disorders, especially for patients with limited access to effective treatments.

Access 97

Access Legalization Research and Development Legislation 97

MMJ Recs

MAY 9, 2024

As such, we provide you with a comprehensive guide for veterans using medical cannabis and the various aspects of it, including its usage, accessibility, legal considerations, healthcare options, and available resources. Navigating the complexities surrounding the Veterans Administration and medical cannabis can be daunting.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Cannabis Law Report

JUNE 14, 2022

PAREA is a non-profit, multistakeholder and multidisciplinary partnership bringing together patient organizations, medical associations, scientific societies, psychedelic foundations, and the for-profit sector. The good news is that innovations that completely change the lives of patients continue to emerge.

Access 52

Access Therapy Clinical Trials Treatment 52

Cannabis Law Report

FEBRUARY 28, 2022

Bronner’s, Partners with Pioneering Health Plan Administrator, Enthea, to Provide Psychedelic Therapy as Employee Healthcare Benefit. Leading US Company to Offer Employee Coverage for Ketamine Assisted Therapy to Promote Mental Health. First Ever Partnership Between Health Plan Administrator and.

Therapy 52

Therapy Treatment Research and Development Advocacy 52

NORML

JUNE 14, 2019

Next week, the two key committees will hold hearings on various aspects of federal marijuana policy. Ultimately, this prohibition on access to resources hampers the potential to create a robust and competitive marketplace for consumers. Small Businesses in the Cannabis Industry. Presently, V.A.

Marijuana 278

Marijuana Access Programs Legislation 278

MMJ Recs

JANUARY 24, 2024

As societal attitudes towards cannabis evolve and the medicinal benefits become increasingly recognized, Michigan’s program stands as a beacon of innovation, providing patients with a legal avenue to explore the therapeutic potential of marijuana. A registered patient or caregiver can possess up to 2.5

Programs 52

Programs Marijuana Access Chronic Pain 52

Cannabis Law Report

MARCH 3, 2020

In Indianapolis on January 29, a quiet, eager audience of nurses give their rapt attention to Jason Straw as he takes center stage at the 2020 ISNA Policy Conference. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. PURPOSE : .

Policy 105

Policy Research and Development Chronic Pain Cannabinoids 105

MMJ Recs

MARCH 20, 2024

Maryland medical cannabis dispensary services Maryland’s medical cannabis dispensaries offer comprehensive services tailored to meet the needs of registered patients. Trained dispensary staff assist patients in product selection, dosage recommendations, and consumption methods, ensuring personalized care and guidance.

Dispensary 52

Dispensary Programs Access Patients 52

Cannabis Law Report

FEBRUARY 9, 2022

This is a breakthrough therapy and it shows promise, but the science is not there yet.”. A Maine therapist with two patients benefiting from psychedelic drug-assisted therapy to treat PTSD and depression also expressed disappointment. She said the patients were not helped by traditional treatments. They were Sen.

Therapy 52

Therapy Treatment Decriminalization Patients 52

MMJ Recs

DECEMBER 26, 2022

Lombardi are Harvard-trained pain physicians who accept most medical insurance policies, including Medicare. This clinic is a specialized “Spine, Sports and Pain Medicine Center” with excellent online patient reviews. Advance Spine and Pain Physical Therapy. You also don’t need a referral to visit this clinic! 19733079495.

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

NORML

JANUARY 24, 2019

It seeks to redefine allowed dosage limitations and formulations, and expand patient access and reduce patient cost by adding nurse practitioners and physician assistants to the list of those authorized to issue written certifications to patients.

Policy 161

Policy Patients Education Legislation 161

Cannabis Law Report

APRIL 12, 2019

I am also prescribed pharmacological and non-pharmacological therapies and try to keep a base of exercise and good nutrition. A patient in Alberta spending $600 (~€397) per month on medical cannabis will pay 24.3% ($145.80) in tax. For most Canadian patients, including myself, this means 24.3%

Access 45

Access Patients Marijuana Medicine 45

MMJ Recs

MARCH 6, 2024

Discover how legalization and regulation have influenced access and usage, and learn about the latest research and medical applications. Legalization and Regulation of Medical Marijuana The journey of legalizing and regulating medical marijuana in the US reflects a nuanced interplay of federal and state policies.

Marijuana 52

Marijuana Chronic Pain Patients Treatment 52

Veriheal

MARCH 20, 2023

Alternative medicine is becoming more widely acknowledged and practiced than ever before, opening the door for therapies like psychedelics to enter the world of mainstream healthcare. Psilocybin therapy is both studied and used by highly legitimate medical establishments. Ned Lamont signed a bill (HB 5506) to fund psychedelic therapy.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

SpeedWeed

MARCH 13, 2021

Almost 25% of patients with Parkinson’s disease reported that they had used cannabis in the prior six months in a survey from the Parkinson’s Foundation. Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success. More Than 1,000 PD Patients Surveyed.

Patients 52

Patients Treatment Therapy Sleep 52

Cannabis Law Report

SEPTEMBER 10, 2021

This exciting partnership between these innovative startups aims to advance patient access to psychedelic treatments in Europe, and improve the quality of the psychedelic medicines produced in Europe. We look forward to working closely with the Clerkenwell Health team to advance our psychedelic drug programs through clinical trials.”.

Research and Development 104

Research and Development Clinical Trials Therapy Environment 104

Cannabis Law Report

JUNE 5, 2021

Among other questions, the poll asked: To what extent would you support or oppose the government relaxing restrictions on research into the medical use of magic mushroom-based treatments (psilocybin- assisted therapies) for mental health conditions if this didn’t affect how it was classified in criminal law (e.g. as a class A drug)?

Therapy 81

Therapy Policy Education Treatment 81

Cannabis Law Report

JULY 29, 2021

Five acquired addiction clinics have conducted 35,000+ patient visits over last 12 months. These assets include 5 addiction treatment clinics across the province of Alberta that have conducted over 35,000 patient visits during the past 12 months. ACT Medical has established Care Teams at each of its locations to serve patients.

Chronic Pain 105

Chronic Pain Treatment Therapy Patients 105

NORML

FEBRUARY 8, 2019

Senator Ron Wyden introduced legislation in the Senate — The Marijuana Revenue and Regulation Act — to permit states to establish their own marijuana regulatory policies free from federal interference. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder.

Legislation 173

Legislation Decriminalization Patients Access 173

NORML

JANUARY 11, 2019

Legislation is pending, Senate Bill 2134, to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes. The measure would permit patients to grow up to nine cannabis plants in a locked, enclosed facility, and to possess up to three ounces of home-grown medical cannabis. ND resident?

Legislation 195

Legislation Decriminalization Hemp Patients 195

Cannabis Law Report

JULY 21, 2022

COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Kabir Nath as Chief Executive Officer, effective August 1, 2022. London, UK July 19, 2022.

Therapy 52

Therapy Research and Development Pharmaceutical Patients 52

NORML

MARCH 14, 2020

Veteran Access : HR 1647, the Veterans Equal Access Act, would allow V.A. Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Your Highness, Carly.

Legislation 186

Legislation Access Patients THC 186

Cannabis Law Report

JUNE 20, 2021

The CIC consists of 97 members dedicated to ensuring a greater understanding of the role of medicinal cannabis, nutraceutical CBD, and hemp across the community and the advancement of medicinal cannabis as an alternate line of therapy. Patient access.

Supply Chain 105

Supply Chain Clinical Trials Research and Development Medicine 105

NORML

FEBRUARY 23, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. It would not allow patients to smoke herbal marijuana or vape, but would allow forms including pills, oils, lozenges and patches. AL resident?

Legislation 239

Legislation Patients Decriminalization Access 239

NORML

FEBRUARY 1, 2019

At the state level, activists in Florida and Missouri gathered in their state capitals along side state and local NORML chapters to lobby state lawmakers in favor of sensible marijuana policy reform. Click here to email your lawmakers in support of banking access. John Fetterman, Lt. CA resident? CT resident? Update : S. FL resident?

Legislation 162

Legislation Decriminalization Access Patients 162

CannaTech

APRIL 17, 2019

CannaTech is a world-leading medical cannabis event bringing together industry mavens, researchers, creators, and policy-makers to accelerate cannabinoid-based innovation. This sector is ever-expanding and endlessly profitable, however all of this growth pivots on the fulcrum of patient access.

Patients 40

Patients Treatment Access Therapy 40

NORML

JANUARY 18, 2019

At the state level, patients in Ohio and Oklahoma now have access to medical cannabis, as sales began in both states this week. A medical cannabis access bill was signed into law in the U.S. If passed, this bill provides registered patients with regulated access to medical cannabis via licensed providers.

Legislation 161

Legislation Decriminalization Access Therapy 161

MMJ Recs

JANUARY 20, 2024

Maryland, a trailblazer in progressive healthcare policies, has been part of this trend. With a nuanced approach to medical marijuana laws, the state has embarked on a journey that seeks to balance patient well-being, regulatory oversight, and societal concerns. As of the latest guidelines, patients are allowed to possess up to 1.5

Law 52

Law Marijuana Patients Chronic Pain 52

NORML

MARCH 7, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. The measure would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder as well as opioid use disorder.

Legislation 231

Legislation Decriminalization Patients THC 231

Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). About MAPS Public Benefit Corporation (MAPS PBC). Executive Summary.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Veriheal

OCTOBER 20, 2021

Veriheal does not support illegally consuming alternative therapeutic substances but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting psychedelic therapy. A Magical Future.

Therapy 98

Therapy Microdosing Decriminalization Consumption 98

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 105

Law Research and Development Therapy DEA 105

The Cannigma

JUNE 2, 2023

The possession, use, and trafficking of cannabis are illegal, and the country maintains a zero-tolerance policy towards drugs. The use of cannabis for medicinal purposes is not permitted, and there are no legal avenues for patients to access cannabis-based medications.

Law 52

Law Research and Development Consumption Therapy 52

Cannabis Law Report

MAY 25, 2022

May 25, 2022 – SACRAMENTO – Senator Scott Wiener (D-San Francisco)’s Senate Bill 1186 , which restores voter-created access to medicinal cannabis across the state by requiring cities to provide patients access to purchase medicinal cannabis by delivery, passed the Senate with a unanimous bipartisan vote.

Medicine 52

Medicine Legislation Chronic Pain Access 52

NORML

MARCH 8, 2019

North Dakota’s first medical cannabis dispensary opened its doors last week in Fargo; and registered out-of-state medical cannabis patients will now be able to access their medicine while visiting Hawaii. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder.

Legislation 168

Legislation Patients Access Seed-To-Sale 168